Results 101 to 110 of about 62,143 (212)

Optimizing the integration of modern systemic therapies and advanced radiotherapy techniques in breast cancer management: An expert opinion from the Institut Curie Breast Radiotherapy Group

open access: yesInternational Journal of Cancer, Volume 158, Issue 7, Page 1775-1784, 1 April 2026.
Abstract The integration of modern systemic therapies with radiotherapy (RT) represents a promising strategy in breast cancer management, enhancing both locoregional control and systemic disease outcomes. This expert consensus from the Institut Curie Breast Radiotherapy Group focuses exclusively on modern systemic agents, synthesizing current evidence ...
Cezara Cheptea   +5 more
wiley   +1 more source

Examining Recruitment and Retention Strategies for Underserved Populations in Thyroid Cancer Clinical Trials: A Cross‐Sectional Analysis

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 2, April 2026.
ABSTRACT Objective(s) Thyroid cancer incidence has risen sharply in the US, with disparities in diagnosis and treatment outcomes disproportionately affecting marginalized populations. Despite mandates for diversity in clinical trials, underrepresentation of these groups remains a critical barrier to equitable health outcomes.
Ryan Sherry   +9 more
wiley   +1 more source

Isocitrate Dehydrogenase‐Mutant Astrocytomas: Risk Stratification and Therapeutic Advance

open access: yesMedComm, Volume 7, Issue 4, April 2026.
This graphical abstract synthesizes the core logic of our revised review by linking integrated diagnosis, risk stratification, and trajectory‐based management in IDH‐mutant astrocytomas across CNS WHO Grades 2–4. It highlights lineage‐defining molecular classification (IDH mutation with core co‐alterations), integrated histomolecular grading, and key ...
Shepeng Wei   +3 more
wiley   +1 more source

Application of Dose-volume Combined with Equivalent Uniform Dose Optimization in Optimization of OAR in IMRT on Nasopharyngeal Carcinoma

open access: yesZhongliu Fangzhi Yanjiu, 2018
Objective To investigate the application of dose-volume (DV) combined with equivalent uniform dose (EUD) in the optimization of organ at risk (OAR) in IMRT on nasopharyngeal carcinoma.
PANG Haowen, SUN Xiaoyang, YANG Bo
doaj   +1 more source

Circulating Microbial Metabolites Predict Tumor Relapse and Chemotherapy Efficacy in Nasopharyngeal Carcinoma

open access: yesMedComm, Volume 7, Issue 4, April 2026.
ABSTRACT The value of microbial metabolites in prognosis and treatment response prediction in patients with nasopharyngeal carcinoma (NPC) remains unclear. Here, through the untargeted metabolomic analysis of plasma in 48 paired NPC patients with or without tumor relapse, we identified distinct circulating metabolite atlases between NPC patients with ...
Jun‐Yan Li   +16 more
wiley   +1 more source

Focal Spot, Summer 2002 [PDF]

open access: yes, 2002
https://digitalcommons.wustl.edu/focal_spot_archives/1091/thumbnail ...

core   +1 more source

Contemporary Management of Malignancies of the Parotid Gland: A State‐of‐the‐Art Review

open access: yesOtolaryngology–Head and Neck Surgery, Volume 174, Issue 4, Page 916-932, April 2026.
Abstract Objectives To provide a systematic update on the contemporary management of malignancies of the parotid gland (MPG), focusing on evidence‐based practices and emerging therapeutics. Data Sources PubMed literature search. Review Methods A search protocol was designed according to the Preferred Reporting Items for Systematic Reviews and Meta ...
Anthony Tang   +10 more
wiley   +1 more source

ZNF844 Suppresses Invasion and Metastasis in Nasopharyngeal Carcinoma by Inhibiting the PI3K‐AKT Signaling Pathway

open access: yesCancer Science, Volume 117, Issue 4, Page 943-957, April 2026.
ZNF844 functions as a tumor suppressor in NPC by inhibiting invasion and metastasis through regulation of the PI3K‐AKT signaling pathway. It may serve as a promising therapeutic target and prognostic biomarker for NPC. ABSTRACT Epigenetic regulation plays a crucial role in the development of nasopharyngeal carcinoma (NPC).
Jinping Xu   +7 more
wiley   +1 more source

The Effect of Managers' Mix of Real and Accrual‐Based Earnings Management on Future Performance

open access: yesJournal of Business Finance &Accounting, Volume 53, Issue 2, Page 681-707, April 2026.
ABSTRACT Prior research finds that firms use both accrual‐based earnings management (AEM) and real earnings management (REM) to manage financial reporting outcomes and that each practice influences firm performance. We extend this research by examining how managers’ choices regarding the mix of AEM and REM relate to future performance.
Bowe Hansen, E. Scott Johnson, Lijun Lei
wiley   +1 more source

Home - About - Disclaimer - Privacy